<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Drug Alcohol Depend</journal-id><journal-id journal-id-type="iso-abbrev">Drug Alcohol Depend</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Drug and alcohol dependence</journal-title></journal-title-group><issn pub-type="ppub">0376-8716</issn><issn pub-type="epub">1879-0046</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10922849</article-id><article-id pub-id-type="pmcid-ver">PMC10922849.319</article-id><article-id pub-id-type="pmcaid">10922849</article-id><article-id pub-id-type="pmcaiid">10922849</article-id><article-id pub-id-type="manuscript-id">NIHMS1970038</article-id><article-id pub-id-type="pmid">38368666</article-id><article-id pub-id-type="doi">10.1016/j.drugalcdep.2024.111125</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1970038</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1970038</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Expanding Access to Medication Treatment for Opioid Use Disorders: Findings from the Washington State Hub and Spoke Effort</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Stewart</surname><given-names initials="MT">Maureen T.</given-names></name><degrees>Ph.D.</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Daily</surname><given-names initials="SM">Shay M.</given-names></name><degrees>Ph.D.</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Thomas</surname><given-names initials="CP">Cindy Parks</given-names></name><degrees>Ph.D.</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Panas</surname><given-names initials="L">Lee</given-names></name><degrees>M.S.</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ritter</surname><given-names initials="G">Grant</given-names></name><degrees>Ph.D.</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Reif</surname><given-names initials="S">Sharon</given-names></name><degrees>Ph.D.</degrees></contrib><aff id="A1">Institute for Behavioral Health, Heller School for Social Policy and Management, Brandeis University, 415 South Street MS 035, Waltham, MA 02453 USA</aff></contrib-group><author-notes><corresp id="CR1"><bold>Corresponding Author:</bold> Maureen T. Stewart, PhD, Senior Scientist, Institute for Behavioral Health, Heller School for Social Policy and Management, Brandeis University, 415 South Street MS 035, Waltham, MA 02453, Phone: 781-736-3717, <email>mstewart@brandeis.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P28">Declaration of competing interest:</p><p id="P29">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this manuscript.</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>3</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>14</day><month>2</month><year>2024</year></pub-date><volume>256</volume><issue-id pub-id-type="pmc-issue-id">457420</issue-id><fpage>111125</fpage><lpage>111125</lpage><pub-history><event event-type="nihms-submitted"><date><day>02</day><month>03</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>01</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-01 00:25:24.073"><day>01</day><month>03</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1970038.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">Opioid use disorder (OUD) is a leading cause of preventable death and injury nationwide. Efforts to increase the use of medication for opioid use disorder (MOUD) are needed. In 2017, Washington State implemented a Hub and Spoke (HS) model of care with the primary goal of expanding access to MOUD. We examined changes in MOUD utilization among Washington State Medicaid beneficiaries before and after HS implementation.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We used Medicaid claims data to examine longitudinal changes in MOUD use for beneficiaries with OUD. We conducted a comparative interrupted time series analysis to examine the association between HS policy implementation and rates of MOUD utilization, overall and by type of medication.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Between 2016 and 2019, a period of increasing OUD prevalence, rates of MOUD utilization among Washington Medicaid beneficiaries increased overall from 39.7 in 2016 to 50.5. Following HS implementation, rates of MOUD use grew at a significantly greater rate in the HS cohort than in the non-HS cohort (&#946;=0.54, SE=0.02, <italic toggle="yes">p</italic>&lt; 0.0001, 95% CI 0.49, 0.59). Analyses by medication type show that this rate increase was primarily due to buprenorphine use (&#946;= 0.61, SE= 0.02, <italic toggle="yes">p</italic>&lt; 0.0001, 95% CI 0.57, 0.65).</p></sec><sec id="S4"><title>Conclusion:</title><p id="P4">Improved systems of care are needed to make MOUD accessible to all patients in need. The Washington HS model is one strategy that may facilitate and expand MOUD use, particularly buprenorphine. Over the study period, Washington State saw increased use of buprenorphine, which was an emphasis of their HS model.</p></sec></abstract><kwd-group><kwd>Opioid Use Disorder</kwd><kwd>Medication for Opioid Use Disorder</kwd><kwd>Medicaid</kwd><kwd>MOUD Utilization</kwd><kwd>Hub and Spoke</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>